Indications and uses
relieves occasional constipation (irregularity) generally causes bowel movement in 6-12 hours
relieves occasional constipation (irregularity) generally causes bowel movement in 6-12 hours
take preferably at bedtime or as directed by a doctor
Sennosides 17.2 mg
Laxative
Do not use laxative products for longer than 1 week unless directed by a doctor
Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These may indicate a serious condition.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| age | startingdosage | maximumdosage |
| adults and children 12 yearsof age and over | 1 tablet once a day | 2 tablets twice aday |
| children 6 to under 12 years | ½ tablet once a day | 1 tablet twice aday |
| children under 6 | ask a doctor | ask a doctor |
croscarmellose sodium, dicalcium phosphate, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, mineral oil, stearic acid, talc, tartaric acid
Senokot® Extra Strength
36 Tablets Carton

Senokot® Extra Strength
12 Tablets Carton

Senokot® Extra Strength 36 Tablets Label

Senokot®
Standardized Senna Concentrate, 17.2mg
Extra
Strength
Natural vegetable
laxative Ingredient
72 Tablets
DO NOT USE IF SEAL UNDER CAP IS
MISSING OR DAMAGED.
A0725
LOT:
EXP:
R54038
Dist. by: Atlantis Consumer Healthcare Inc.
Bridgewater, NJ 08807 USA
Questions? 1-833-288-2684
www.senokot.com
©2025 Atlantis Consumer Healthcare Inc.


| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 602802 | sennosides 17.2 MG Oral Tablet | PSN | 11 |
| 1039965 | SenokotXTRA 17.2 MG Oral Tablet | PSN | 11 |
| 1039965 | sennosides, USP 17.2 MG Oral Tablet [Senokot] | SBD | 11 |
| 602802 | sennosides, USP 17.2 MG Oral Tablet | SCD | 11 |
| 1039965 | Senokot 17.2 MG Oral Tablet | SY | 11 |
| 1039965 | SenokotXTRA 17.2 MG Oral Tablet | SY | 11 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67618-120-06 | Senokot | 36 in 1 BOTTLE | TABLET, FILM COATED | 36 | 11 | |
| 67618-120-12 | Senokot | 12 in 1 BLISTER PACK | TABLET, FILM COATED | 12 | 11 | |
| 67618-120-12 | Senokot | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 11 | |
| 67618-120-36 | Senokot | 12 in 1 BLISTER PACK | TABLET, FILM COATED | 12 | 11 | |
| 67618-120-36 | Senokot | 3 in 1 CELLO PACK | TABLET, FILM COATED | 3 | 11 | |
| 67618-120-72 | Senokot | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 11 | |
| 67618-120-72 | Senokot | 2 in 1 PACKAGE | TABLET, FILM COATED | 2 | 11 | |
| 67618-120-73 | Senokot | 72 in 1 BOTTLE | TABLET, FILM COATED | 72 | 11 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67618-120-06 | EA - Each | 67618-120 | 77b005d4-d653-4a7e-8850-a12ceecdc616 | 1 | 2021-03-02 |
| 67618-120-12 | EA - Each | 67618-120 | 452e375b-566f-4df5-84ed-67a65d226ecc | 1 | 2017-03-06 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 67618-120 | 67618-120-12, 67618-120-36, 67618-120-06, 67618-120-72, 67618-120-73 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| SENNOSIDES | 3FYP5M0IJX | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| HYPROMELLOSE, UNSPECIFIED | 3NXW29V3WO | IACT |
| LACTOSE, UNSPECIFIED FORM | J2B2A4N98G | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| TARTARIC ACID | W4888I119H | IACT |
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | O7TSZ97GEP | IACT |
| LIGHT MINERAL OIL | N6K5787QVP | IACT |
| TALC | 7SEV7J4R1U | IACT |
| STEARIC ACID | 4ELV7Z65AP | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senokot | STANDARDIZED SENNA CONCENTRATE | Atlantis Consumer Healthcare, Inc. | d5bf67e5-82c6-edbf-e9ec-e027fdd47c84 | 2025-08-20 | Warnings | 67618-120-72 67618-120-36 67618-120-12 67618-120-73 67618-120-06 67618-120 67618012073 67618012036 67618012072 67618012012 67618012006 8319c8b6-8d3f-416d-a864-39cb879df2da d5bf67e5-82c6-edbf-e9ec-e027fdd47c84 |
Adverse event summaries are temporarily unavailable. Other product information remains available.